From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Avacta: more non news on the Covid horse that has already bolted ahead of more spiv selling tomorrow

By Tom Winnifrith, The Sheriff of AIM | Wednesday 24 June 2020


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


With shares in Avacta (AVCT) ludicrously overvalued at 138p the company rightly fears that when the second tranche of stock from the recent placing at 120p is admitted to the AIM Casino tomorrow there will be a line of folks wanting to flip. What to do? Of course, get your evil morally bankrupt PR spinners at Yellow Jersey to issue complete non news and make it sound exciting. Heck Yellow Jersey managed to persuade suckers to pile into mega and obvious fraud Frontera (FRR) so they can push any shite uphill. For a while at least.

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 12:22:31